PLoS ONE · 2018 · 12 citations · 35 references
MedicineBiochemistryCardiologyBone MetabolismMineral MetabolismProteomicsAcute Ischemic StrokeBone Metabolism DisordersBone TurnoverCerebrovascular DiseaseStrokeThrombosisBiomarkers Of Ischemic InjuryBone Formation MarkersBone Resorption MarkersBone Turnover AssessmentDiagnostic Bone MarkersIschemic Stroke PathophysiologyPlaque Stability
BACKGROUND: The major cause of ischemic stroke is unstable or thrombogenic atherosclerotic plaques. Vascular calcification, a process that appears crucial for plaque stability, shares common features with bone formation. Many bone turnover proteins exhibit metabolic properties, but the evidence is conflicting regarding their possible involvement in vascular disease. Antibodies against sclerostin and dickkopf-1 are currently being evaluated as potential therapy for treating bone disorders. It is important to carefully assess the cardiovascular and metabolic effects of these proteins. The aim of the present study was to explore serum levels of bone turnover markers in patients with acute noncardio-embolic ischemic stroke in comparison with healthy controls. METHODS: In a cross-sectional study, we compared 48 patients aged ≥75 years with noncardio-embolic ischemic stroke and 46 healthy controls. Serum levels of dickkopf-1, sclerostin, osteoprotegerin, osteopontin and osteocalcin were determined by Luminex technique. RESULTS: We found clearly increased serum levels of osteoprotegerin, sclerostin, dickkopf-1 and osteopontin in patients with stroke compared with healthy controls. No difference was seen in serum levels of osteocalcin between the two groups. CONCLUSION: Our findings strengthen the hypothesis of bone turnover markers being involved in vascular disease. Whether these proteins can be used as candidate markers for increased stroke risk or prognostic biomarkers remains to be further elucidated.
35
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung, Andreas Grauer, Steven Boonen et al. · New England Journal of Medicine · 2014 · 1.2K citations
Brian J. Bennett, Marta Scatena, Elizabeth A. Kirk et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2006 · 301 citations · Full text